Cives
Centro de Informação em Saúde para Viajantes
Center on Health Information for Travellers


 Yellow fever in Brazil: 2008

 From December 2007 to January 18, 2008, the Ministry of Health informs has received 33 reports of suspected cases of yellow fever.  Of these, twelve cases have been officially confirmed (eight developed to death), fourteen were discarded and the others are still under investigation.  The confirmed cases, probably acquired the disease in Goias and Mato Grosso do Sul
 

 Although the infection has occurred in the rural area (transmission wild), the cases of yellow fever, in general, are recognized and diagnosed in urban areas.  During the period in which the virus of yellow fever is present in the blood, a person can serve as a source of infection for the mosquito.  In Rio de Janeiro, as in other cities, there is a Aëdes aegypti mosquito, which transmits the dengue, but can transmit yellow fever.  Therefore, the possibility exists of transmission urban permanently since the reintroduction of the Aëdes aegypti in Brazilian cities, in the eighties.
 

 That risk can be significantly reduced with the vaccination, at least ten days before the trip, from people who are directed to areas of transmission of yellow fever, with the fight for effective Aëdes and with the routine vaccination of populations living in areas of risk.  Moreover, it is necessary to enlarge the capacity of the surveillance system to make it capable of detecting early suspected cases, including less exuberant.
 

 The Cives recommends that the traveler be vaccinated against yellow fever, resalvando up the contra-indications, at least ten days before we go to any area - even the urban-regions with risk of transmission of yellow fever in Brazil. In addition, recommends that travelers carefully observe the measures of protection against diseases transmitted by insects. To travellers from areas of risk of transmission of yellow fever should be vaccinated as part of routine vaccination of these regions, regardless of the destination.
 

 The yellow fever vaccine (17D) is prepared with the live attenuated virus.  In 95% of people the protective effect (immunity) occurs one week of application.  It confers immunity for at least 10 years (probably longer in most vaccinated).  Therefore, individuals previously vaccinated only require subsequent dose of the vaccine after 10 years. In Brazil, the vaccine is part of the basic scheme of children in the states where the disease is endemic.


Yellow fever: risk areas